3WX-10853-26945
4 vaccinations
6 coded responses
43 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 915 / CA
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-18
Dose 1 — Pfizer-BioNTech
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 2 — Pfizer-BioNTech
-
2021-03-12
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Itching · Headache, NauseaAdult check-in
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-06-11
- 2021-09-10
-
2021-10-18
Dose 3 — Pfizer-BioNTech
-
2021-10-20
Survey response — days 1–6 daily, dose 3MedDRA: Dyspepsia — Feeling: Fair · Fatigue or tiredness, NauseaFree text: heartburnMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-22
Survey response — days 1–6 daily, dose 3MedDRA: Flatulence — Feeling: Good · Fatigue or tiredness, NauseaFree text: GassyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-23
Survey response — days 1–6 daily, dose 3MedDRA: Dyspepsia — Feeling: Good · Fatigue or tiredness, NauseaFree text: HeartburnMedDRA releases: 2024-11 · check-in free text available
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Constipation — Feeling: Good · Fatigue or tiredness, NauseaFree text: ConstipationMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — day 7, dose 3MedDRA: Upper-airway cough syndrome — Feeling: Good · Fatigue or tiredness, NauseaFree text: Slight nasal dripMedDRA releases: 2024-11 · check-in free text available
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
-
2022-01-17
Survey response — 3 months, dose 3MedDRA: Upper-airway cough syndrome — Feeling: GoodFree text: Post Nasal DripMedDRA releases: 2024-11 · check-in free text available
- 2022-04-18
-
2022-09-20
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-20
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-09-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-12-20
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Pfizer-BioNTech | |
| 2 | 2021-03-12 | Pfizer-BioNTech | |
| 3 | 2021-10-18 | Pfizer-BioNTech | No |
| 4 | 2022-09-20 | Pfizer-BioNTech | Flu |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): heartburn
Systemic reaction (other): Gassy
Systemic reaction (other): Heartburn
Systemic reaction (other): Constipation
Release 10 — day 7, dose 3
Systemic reaction (other): Slight nasal drip
Release 10 — 3 months, dose 3
Symptoms: Post Nasal Drip
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Constipation | · | · | ✓ |
| SRO | Dyspepsia | · | · | ✓ |
| SRO | Flatulence | · | · | ✓ |
| SRO | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release